Alignment Healthcare, Inc. (ALHC) P/E Ratio History
Historical price-to-earnings valuation from 2026 to 2026
Loading P/E history...
ALHC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Alignment Healthcare, Inc. (ALHC) trades at a price-to-earnings ratio of -4845.9x, with a stock price of $17.93 and trailing twelve-month earnings per share of $0.09.
The current P/E is 2515% below its 5-year average of 200.7x. Over the past five years, ALHC's P/E has ranged from a low of 200.7x to a high of 200.7x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.2x, ALHC trades at a 21930% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 176.0x.
Relative to the broader market, ALHC trades at a notable discount to the S&P 500 median P/E of 24.9x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our ALHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
ALHC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $10B | 20.8 | - | -56% | |
| $116B | 65.1 | - | -62% | |
| $33B | 27.9 | - | -1% | |
| $82B | 15.1 | 2.18 | -2% | |
| $33B | 8.1 | 0.28Best | +4%Best | |
| $13M | 8.0Lowest | - | -4% | |
| $345B | 28.7 | - | -15% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
ALHC Historical P/E Data (2026–2026)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2026 Q1 | $17.62 | $0.09 | 200.7x | +0% |
Average P/E for displayed period: 200.7x
See ALHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ALHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ALHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonALHC — Frequently Asked Questions
Quick answers to the most common questions about buying ALHC stock.
Is ALHC stock overvalued or undervalued?
ALHC trades at -4845.9x P/E, below its 5-year average of 200.7x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does ALHC's valuation compare to peers?
Alignment Healthcare, Inc. P/E of -4845.9x compares to sector median of 22.2x. The discount suggests lower growth expectations or higher risk.
What is ALHC's PEG ratio?
ALHC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2026-2026.